N/A
Completed N=1,185
Evaluating a Patient-Centered Tool to Help Medicare Beneficiaries Choose Prescription Drug Plans
Prescription Drug Insurance Decision Making
Source: ClinicalTrials.gov NCT02895295 ↗
Enrolled (actual)
1,185
Serious AEs
—
Results posted
Jul 2019
Primary outcomePrimary: Count of Participants Whose 2017 Plan Differed From Their 2016 Plan — 85; 110; 86 Participants
Summary
The objective of this study is to determine whether providing Medicare beneficiaries with a web-based patient-centered decision tool to help them choose among prescription medication coverage plans improves outcomes for patients including a greater likelihood of changing a plan, better coverage for prescribed drugs, less decisional conflict when choosing plans, and greater satisfaction with the choice process relative to current practice.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Count of Participants Whose 2017 Plan Differed From Their 2016 Plan |
85; 110; 86 | — |
| PRIMARY Decisional Conflict |
21.06; 20.86; 19.56 | — |
| PRIMARY Satisfaction With the Choice Process |
122; 148; 134 | — |
| PRIMARY Change in Estimated Prescription Drug Spending |
-178.90; -249.59; -197.29 | — |
Eligibility Criteria
Inclusion Criteria
- The study population included Medicare beneficiaries who received care from the Palo Alto Medical Foundation, a large multi-specialty group in the San Francisco Bay Area ages 66-85, one per household enrolled in a Medicare Part D plan in 2016.
Exclusion Criteria
- Enrolled in a Medicare Advantage Plan and/or MediCal
Data sourced from ClinicalTrials.gov (NCT02895295). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.